News Novel Drug, First Tx Approved for Rare Uveal Melanoma by Medscape • 2022/01/27 • 0 Comments A novel drug, the first in its class, is also the first treatment approved for use in uveal melanoma, a rare cancer of the eye, after it was shown to improve overall survival. FDA Approvals Full Story →